INVICTA

Invicta Diagnostic Share Price

 

 

Start SIP in INVICTA

Start SIP

Performance

  • Low
  • ₹70
  • High
  • ₹73
  • 52 Week Low
  • ₹65
  • 52 Week High
  • ₹105
  • Open Price₹70
  • Previous Close₹71
  • Volume11,200
  • 50 DMA-
  • 100 DMA-
  • 200 DMA-

Investment Returns

  • Over 1 Month -19.28%
  • Over 3 Month -18%
  • Over 6 Month -18%
  • Over 1 Year -18%

Smart Investing Starts Here Start SIP with Invicta Diagnostic for Steady Growth!

Invest Now

Invicta Diagnostic Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 18.8
  • PEG Ratio
  • -
  • Market Cap Cr
  • 88
  • P/B Ratio
  • 3.2
  • Average True Range
  • 5.39
  • EPS
  • 3.73
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 24.82
  • MFI
  • 35.13

Invicta Diagnostic Financials

Invicta Diagnostic Technicals

EMA & SMA

Current Price
₹69.70
-1.15 (-1.62%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 0
  • 20 Day
  • ₹79.71
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

70.65 Pivot Speed
  • R3 74.45
  • R2 73.50
  • R1 71.60
  • S1 68.75
  • S2 67.80
  • S3 65.90

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

N/A

Group Rank

Invicta Diagnostic Ltd has an operating revenue of Rs. 38.46 Cr. on a trailing 12-month basis. An annual revenue growth of 265% is outstanding, Pre-tax margin of 23% is great, ROE of 27% is exceptional. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 32% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 15 which is POOR indicating the underperformance as compared to other stocks, Group Rank of 68 indicates it belongs to a poor industry group of Medical-Services and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Invicta Diagnostic F&O

Invicta Diagnostic Shareholding Pattern

66.7%
0.94%
18.49%
13.87%

Invicta Diagnostic FAQs

Invicta Diagnostic share price is ₹69 As on 13 January, 2026 | 21:50

The Market Cap of Invicta Diagnostic is ₹87.6 Cr As on 13 January, 2026 | 21:50

The P/E ratio of Invicta Diagnostic is 18.8 As on 13 January, 2026 | 21:50

The PB ratio of Invicta Diagnostic is 3.2 As on 13 January, 2026 | 21:50

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23